AUG 20, 2014 11:45 AM PDT

Genetic Counseling Post-SCOTUS Patent Decision: Fast Forward

Speakers
  • Founder and CEO, Gene Counsel
    Biography
      Ellen T. Matloff, M.S., C.G.C., received her Bachelor's degree in Biology from Union College, her Master's degree in Genetic Counseling from Northwestern University, and her board certification from the American Board of Genetic Counseling.  Matloff was the Founder and Director of the Cancer Genetic Counseling Program at Yale School of Medicine until July 2014 and is the Founder and CEO of Gene Counsel (mygenecounsel.com). Her interests include patient and provider issues in genetic counseling, adverse events in genetic testing and the impact of patents on clinical practice. Ms. Matloff was a lead plantiff in the 2013 Supreme Court case against gene patenting.

    Abstract:

    The unanimous Supreme Court ruling of 2013 regarding gene patents made competition for BRCA1 and BRCA2 testing a reality. Within hours of the decision multiple labs began offering more comprehensive BRCA testing at lower prices. Most of these laboratories also offered BRCA1 and 2 on a panel with many genes involved in cancer development. Most of these genes are lesser studied and understood than BRCA1 and 2 and often include variants of uncertain significance. Deciphering if a mutation is clinically relevant, how that patient should be followed, if the genetic finding is actually responsible for the cancers in the family and segregates with disease, and determining whether carrier status is important to the surveillance, chemoprovention and prophylactic surgery recommendations made to the patient has greatly increased the complexity of the field. All of this information will be discussed as well as what we can expect from the field as whole-exome sequencing becomes a clinical reality.


    Show Resources
    You May Also Like
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    Loading Comments...